Literature DB >> 16763973

Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.

Isabelle Catalaa1, Roland Henry, William P Dillon, Edward E Graves, Tracy R McKnight, Ying Lu, Daniel B Vigneron, Sarah J Nelson.   

Abstract

PURPOSE: To evaluate perfusion, diffusion, and spectroscopy values in enhancing and non-enhancing lesions for patients with newly diagnosed gliomas of different grades.
MATERIALS AND METHODS: Sixty-seven patients with newly diagnosed glioma were entered into the study 20 grade II, 26 grade III and 21 grade IV. MR data were acquired at 1.5T and included diffusion weighted images (59/67 patients), dynamic perfusion weighted images (30/67 patients) and 3D H-1 MR spectroscopy (64/67 patients). Enhancing and non-enhancing lesions were delineated by a neuroradiologist and applied to maps of relative cerebral blood volume (rCBV), apparent diffusion coefficient (ADC), relative anisotropy (RA) and metabolite intensities.
RESULTS: The median rCBV within enhancing regions of grade IV gliomas was significantly elevated relative to enhancing regions in grade III gliomas and normal brain. ADC was elevated relative to normal brain, but was not significantly different between grades or between enhancing and non-enhancing regions. The RA was higher in the non-enhancing region of grade IV gliomas relative to grade II and grade III. Levels of lactate plus lipid were significantly elevated in grade IV relative to grade II and grade III gliomas. Both enhancing and non-enhancing regions in grade IV gliomas showed significant correlations between CBV, ADC and choline levels.
CONCLUSION: The data were consistent with grade IV gliomas having higher membrane turnover, increased cell density and increased vascularity within enhancing lesions. Analysis of the correlations among parameters within grade IV gliomas suggested that high vascularity (high rCBV) was correlated with increased cellularity (low ADC) and increased membrane turnover (high choline) in these lesions. The non-enhancing region of grades II and III gliomas had MR parameters consistent with increased cellularity and/or membrane turnover. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16763973     DOI: 10.1002/nbm.1059

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  40 in total

1.  In vivo characterization of several rodent glioma models by 1H MRS.

Authors:  Sabrina Doblas; Ting He; Debra Saunders; Jessica Hoyle; Nataliya Smith; Quentin Pye; Megan Lerner; Randy L Jensen; Rheal A Towner
Journal:  NMR Biomed       Date:  2011-09-23       Impact factor: 4.044

Review 2.  Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.

Authors:  Alba A Brandes; Alicia Tosoni; Federica Spagnolli; Giampiero Frezza; Marco Leonardi; Fabio Calbucci; Enrico Franceschi
Journal:  Neuro Oncol       Date:  2008-04-09       Impact factor: 12.300

3.  Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.

Authors:  P Tiwari; P Prasanna; L Wolansky; M Pinho; M Cohen; A P Nayate; A Gupta; G Singh; K J Hatanpaa; A Sloan; L Rogers; A Madabhushi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

4.  Stretched-exponential model diffusion-weighted imaging as a potential imaging marker in preoperative grading and assessment of proliferative activity of gliomas.

Authors:  Xiaowei Chen; Jingjing Jiang; Nanxi Shen; Lingyun Zhao; Jiaxuan Zhang; Yuanyuan Qin; Shun Zhang; Li Li; Wenzhen Zhu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

5.  Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Domenico Catapano; Giuseppe M Giannatempo; Simona Bonavita; Maurizio Portaluri; Michela Tosetti; Vincenzo A d'Angelo; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

6.  The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.

Authors:  Dita Wagnerova; Filip Jiru; Monika Dezortova; Lydie Vargova; Eva Sykova; Milan Hajek
Journal:  MAGMA       Date:  2008-10-25       Impact factor: 2.310

7.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

8.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Relationship between choline and apparent diffusion coefficient in patients with gliomas.

Authors:  Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

10.  Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?

Authors:  S Rose; M Fay; P Thomas; P Bourgeat; N Dowson; O Salvado; Y Gal; A Coulthard; S Crozier
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.